TRIAL FOR EVALUATING THE EFFICACY OF A NEW LEADLESS DEFIBRILLATOR SYSTEM
- Conditions
- Pulmonary heart disease, unspecified,
- Registration Number
- CTRI/2022/04/042267
- Lead Sponsor
- CALYAN CARDIAC THERAPEUTICS INDIA PVT LTD
- Brief Summary
This is A prospective, multi-site, single-arm, open-label feasibility study. This study is designed to evaluate the efficacy implant procedure and placement of the Calyan leadless defibrillator, and to evaluate the feasibility of defibrillation.Subjects Scheduled for ICD implantation will be recruited in the study.The device will be connected to anexternal defibrillator or ICD pulse generator, and defibrillation testing (ventricularfibrillation induction and cardioversion) will be performed.
The data from this study will be used to refine the device design, and to justify further investigation of the leadless defibrillation system.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- All
- Target Recruitment
- 5
- Female or male 2.
- Age 18 or above 3.
- Willing and capable of providing informed consent 4.
- Scheduled for ICD implantation.
- Patients with have previously undergone an open heart surgical procedure 2.
- Currently implanted with a cardiac pacemaker, implantable cardioverter defibrillator, cardiac resynchronization, or neurostimulation device.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method defibrillation of the ventricle with the leadless defibrillation system. VISIT 2 Efficacy endpoint will be the number of patients with successful VISIT 2
- Secondary Outcome Measures
Name Time Method Secconary endpoint will be the number of patients with successful defibrillation of the ventricle with the leadless defibrillation system.
Trial Locations
- Locations (1)
Metromed International Cardiac Centre
🇮🇳Kozhikode, KERALA, India
Metromed International Cardiac Centre🇮🇳Kozhikode, KERALA, IndiaProf Dr V NandakumarPrincipal investigator8592851444prof.nandakumarv@gmail.com